Stable/JJ
expression/NN
of/IN
transdominant/JJ
Rev/NN
protein/NN
in/IN
human/JJ
T/NN
cells/NNS
inhibits/VBZ
human/JJ
immunodeficiency/NN
virus/NN
replication/NN
./.

The/DT
human/JJ
immunodeficiency/NN
virus/NN
(/(
HIV/NN
)/)
Rev/NN
protein/NN
is/VBZ
essential/JJ
for/IN
viral/JJ
structural/JJ
protein/NN
expression/NN
(/(
Gag/NN
,/,
Pol/NN
,/,
and/CC
Env/NN
)/)
and/CC
,/,
hence/RB
,/,
for/IN
viral/JJ
replication/NN
./.
=====
In/IN
transient/JJ
transfection/NN
assays/NNS
,/,
mutant/JJ
forms/NNS
of/IN
Rev/NN
have/VBP
been/VBN
identified/VBN
that/WDT
inhibit/VBP
wild-type/JJ
Rev/NN
activity/NN
and/CC
therefore/RB
suppress/VBP
viral/JJ
replication/NN
./.
=====
To/TO
determine/VB
whether/IN
such/JJ
transdominant/JJ
Rev/NN
proteins/NNS
could/MD
provide/VB
long-term/JJ
protection/NN
against/IN
HIV/NN
infection/NN
without/IN
affecting/VBG
T/NN
cell/NN
function/NN
,/,
T/NN
leukemia/NN
cell/NN
lines/NNS
were/VBD
stably/RB
transduced/VBN
with/IN
a/DT
retroviral/JJ
vector/NN
encoding/VBG
a/DT
transdominant/JJ
mutant/NN
of/IN
the/DT
Rev/NN
protein/NN
,/,
M10/NN
./.
=====
While/IN
all/PDT
the/DT
M10-expressing/JJ
cell/NN
lines/NNS
remained/VBD
infectable/JJ
by/IN
HIV-1/NN
,/,
these/DT
same/JJ
cells/NNS
failed/VBD
to/TO
support/VB
a/DT
productive/JJ
replication/NN
cycle/NN
when/WRB
infected/VBN
with/IN
a/DT
cloned/VBN
isolate/NN
of/IN
HIV-1/NN
./.
=====
In/IN
addition/NN
,/,
two/CD
out/IN
of/IN
three/CD
M10-expressing/JJ
CEM/NN
clones/NNS
were/VBD
also/RB
resistant/JJ
to/TO
highly/RB
productive/JJ
infection/NN
by/IN
a/DT
heterogeneous/JJ
HIV-1/NN
pool/NN
./.
=====
Expression/NN
of/IN
M10/NN
did/VBD
not/RB
affect/VB
induction/NN
of/IN
HIV/NN
transcription/NN
mediated/VBN
by/IN
the/DT
kappa/NN
B/NN
regulatory/JJ
element/NN
or/CC
Tat/NN
./.
=====
Importantly/RB
,/,
constitutive/JJ
expression/NN
of/IN
Rev/NN
M10/NN
did/VBD
not/RB
alter/VB
the/DT
secretion/NN
of/IN
interleukin/NN
2/CD
in/IN
response/NN
to/TO
mitogen/NN
stimulation/NN
of/IN
EL-4/NN
and/CC
Jurkat/NN
cells/NNS
./.
=====
The/DT
inhibition/NN
of/IN
HIV/NN
infection/NN
in/IN
cells/NNS
stably/RB
expressing/VBG
a/DT
transdominant/JJ
Rev/NN
protein/NN
,/,
in/IN
the/DT
absence/NN
of/IN
any/DT
deleterious/JJ
effect/NN
on/IN
T/NN
cell/NN
function/NN
,/,
suggests/VBZ
that/IN
such/PDT
a/DT
strategy/NN
could/MD
provide/VB
a/DT
therapeutic/JJ
effect/NN
in/IN
the/DT
T/NN
lymphocytes/NNS
of/IN
acquired/VBN
immunodeficiency/NN
syndrome/NN
patients/NNS
./.